Diero, L. O.Fife, K. H.Kaloustian, K. W.Sidle, J.Dube, M. P.Fife, R. S.Mureithi, J.Mwangi, A.Association of Kenya Physicians Scientific Conference (11th : Mar. 2007 : Eldoret, Kenya)2007-10-252007-10-252007https://hdl.handle.net/1805/1158Changes in fat distribution has been observed in patients on highly active antiretroviral therapy. The frequently reported drugs that cause fat redistribution are stavudine and protease inhibitors. Stavudine also causes a high incidence of metabolic complications and peripheral neuropathy.enLipodystrophyHIVAntiretroviral therapyKenyaAfricaKenyaHIV-Associated Lipodystrophy SyndromeAntiretroviral Therapy, Highly ActiveHIVPresentation